Cinctive Capital Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-79,997
Closed -$1.99M 581
2022
Q1
$1.99M Buy
79,997
+22,100
+38% +$571K 0.07% 329
2021
Q4
$1.86M Buy
57,897
+4,889
+9% +$179K 0.08% 314
2021
Q3
$1.91M Buy
53,008
+42,109
+386% +$1.66M 0.09% 303
2021
Q2
$481K Buy
+10,899
New +$475K 0.02% 420
2021
Q1
Sell
-31,180
Closed -$2.15M 464
2020
Q4
$2.15M Buy
+31,180
New +$1.53M 0.18% 218

Other funds holding LUNG

Cinctive Capital Management's LUNG Position: Q2 2022 in Review

Cinctive Capital Management sold out of Pulmonx (LUNG) in Q2 2022, closing a stake of 79,997 shares — an estimated $1.99M sold.

Cinctive Capital Management first reported a position in LUNG in Q4 2020 and held it in 5 quarters. The position peaked at $2.15M in Q4 2020. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2022.

  • Cinctive Capital Management reported no remaining Pulmonx position as of Q2 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 79,997 Pulmonx shares in Q2 2022, an estimated $1.99M.
  • Cinctive Capital Management first reported a position in Pulmonx in Q4 2020 and held it in 5 quarters.
  • Cinctive Capital Management's Pulmonx position peaked at $2.15M in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2022.

Based on Cinctive Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.